Mexedia SpA SB
PAR:ALMEX
Mexedia SpA SB
PAR:ALMEX
Price:
8.2
EUR
-2.26%
Market Closed
Market Cap:
€46.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Mexedia SpA SB
PAR:ALMEX
|
IT |
|
Rakuten Group Inc
OTC:RKUNF
|
JP |
|
Guizhou Chanhen Chemical Corp
SZSE:002895
|
CN |
|
P
|
Philomaxcap AG
F:HBD1
|
DE |
|
Volkswagen AG
XETRA:VOW
|
DE |
|
Exor NV
AEX:EXO
|
NL |
|
International Flavors & Fragrances Inc
NYSE:IFF
|
US |
|
Low Keng Huat (Singapore) Ltd
SGX:F1E
|
SG |
|
P
|
PT Menthobi Karyatama Raya Tbk
IDX:MKTR
|
ID |
|
O
|
Orosur Mining Inc
XTSX:OMI
|
CA |
|
Catapult Group International Ltd
ASX:CAT
|
AU |
|
Onmobile Global Ltd
NSE:ONMOBILE
|
IN |
|
Blackstone Secured Lending Fund
F:GM8
|
US |
|
E
|
E Investment&Development Co Ltd
KRX:093230
|
KR |
|
Hans Energy Co Ltd
HKEX:554
|
HK |
|
Adobe Inc
NASDAQ:ADBE
|
US |
|
ACS Actividades de Construccion y Servicios SA
MAD:ACS
|
ES |
|
Loop Energy Inc
OTC:LPENF
|
CA |
|
Berkeley Energia Ltd
ASX:BKY
|
UK |
|
Hercules SA Fabrica De Talheres
BOVESPA:HETA4
|
BR |
|
Hexo Corp
TSX:HEXO
|
CA |
|
S
|
SciClone Pharmaceuticals (Holdings) Ltd
HKEX:6600
|
CN |
|
Argosy Minerals Ltd
ASX:AGY
|
AU |
|
M
|
Maat Pharma SA
PAR:MAAT
|
FR |
Balance Sheet
Balance Sheet Decomposition
Mexedia SpA SB
Mexedia SpA SB
Balance Sheet Decomposition is not available for
Mexedia SpA SB
Mexedia SpA SB
Balance Sheet
Mexedia SpA SB
Mexedia SpA SB
Currency: EUR
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
0
|
4
|
6
|
3
|
1
|
2
|
|
| Cash |
0
|
0
|
6
|
3
|
0
|
2
|
|
| Cash Equivalents |
0
|
4
|
0
|
0
|
1
|
0
|
|
| Total Receivables |
17
|
20
|
25
|
39
|
100
|
73
|
|
| Accounts Receivables |
16
|
19
|
16
|
29
|
91
|
73
|
|
| Other Receivables |
0
|
1
|
9
|
10
|
10
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
17
|
25
|
30
|
42
|
101
|
75
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
10
|
15
|
|
| Goodwill |
0
|
0
|
55
|
55
|
56
|
59
|
|
| Long-Term Investments |
2
|
2
|
0
|
0
|
1
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
9
|
|
| Other Assets |
0
|
0
|
55
|
55
|
56
|
59
|
|
| Total Assets |
19
N/A
|
27
+40%
|
85
+214%
|
97
+14%
|
169
+74%
|
158
-7%
|
|
| Liabilities | |||||||
| Accounts Payable |
14
|
9
|
3
|
4
|
57
|
59
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
8
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
24
|
29
|
42
|
0
|
|
| Other Current Liabilities |
1
|
3
|
0
|
1
|
3
|
7
|
|
| Total Current Liabilities |
15
|
20
|
27
|
34
|
102
|
67
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
5
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
7
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
45
|
|
| Total Liabilities |
15
N/A
|
20
+34%
|
27
+39%
|
34
+26%
|
102
+197%
|
110
+8%
|
|
| Equity | |||||||
| Common Stock |
0
|
0
|
57
|
57
|
57
|
57
|
|
| Retained Earnings |
3
|
5
|
1
|
6
|
10
|
10
|
|
| Unrealized Security Profit/Loss |
2
|
2
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
5
N/A
|
8
+60%
|
58
+671%
|
63
+8%
|
67
+7%
|
47
-29%
|
|
| Total Liabilities & Equity |
19
N/A
|
27
+40%
|
85
+214%
|
97
+14%
|
169
+74%
|
158
-7%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
6
|
6
|
6
|
6
|
6
|
6
|
|
Switch to:
Switch to:
See Also
Discover More
